vs
Side-by-side financial comparison of H2O AMERICA (HTO) and Travere Therapeutics, Inc. (TVTX). Click either name above to swap in a different company.
H2O AMERICA is the larger business by last-quarter revenue ($199.4M vs $129.7M, roughly 1.5× Travere Therapeutics, Inc.). On growth, Travere Therapeutics, Inc. posted the faster year-over-year revenue change (73.4% vs 1.5%). Over the past eight quarters, Travere Therapeutics, Inc.'s revenue compounded faster (77.0% CAGR vs 15.3%).
H2O Wireless is a United States-based prepaid cell phone service, that utilizes the AT&T network. It is a brand of the mobile virtual network operator (MVNO) Locus Telecommunications, a subsidiary of Telrite Holdings, Inc., since 2019. Locus was formerly a subsidiary of KDDI America corporation, starting in 2010. H2O Wireless is primarily advertised as a non-restrictive phone service for customers to bring or buy unlocked smartphones, although AT&T contract/locked phones may be accepted as well.
Travere Therapeutics, Inc. is a global biopharmaceutical firm developing and commercializing innovative therapies for patients with rare, serious, life-threatening diseases. Its key segments cover rare nephrology, hepatology and metabolic disorders, serving markets across North America, Europe and other global regions.
HTO vs TVTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $199.4M | $129.7M |
| Net Profit | $16.2M | — |
| Gross Margin | — | 98.0% |
| Operating Margin | 16.6% | -25.0% |
| Net Margin | 8.1% | — |
| Revenue YoY | 1.5% | 73.4% |
| Net Profit YoY | -29.2% | — |
| EPS (diluted) | $0.45 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $199.4M | $129.7M | ||
| Q3 25 | $243.5M | $164.9M | ||
| Q2 25 | $197.8M | $114.4M | ||
| Q1 25 | $164.9M | $81.7M | ||
| Q4 24 | $196.5M | $74.8M | ||
| Q3 24 | $216.7M | $62.9M | ||
| Q2 24 | $173.1M | $54.1M | ||
| Q1 24 | $150.0M | $41.4M |
| Q4 25 | $16.2M | — | ||
| Q3 25 | $45.1M | $25.7M | ||
| Q2 25 | $24.7M | $-12.8M | ||
| Q1 25 | $16.6M | $-41.2M | ||
| Q4 24 | $22.9M | — | ||
| Q3 24 | $38.7M | $-54.8M | ||
| Q2 24 | $20.7M | $-70.4M | ||
| Q1 24 | $11.7M | $-136.1M |
| Q4 25 | — | 98.0% | ||
| Q3 25 | — | 99.0% | ||
| Q2 25 | — | 98.7% | ||
| Q1 25 | — | 94.3% | ||
| Q4 24 | — | 96.6% | ||
| Q3 24 | — | 97.4% | ||
| Q2 24 | — | 96.2% | ||
| Q1 24 | — | 96.4% |
| Q4 25 | 16.6% | -25.0% | ||
| Q3 25 | 26.5% | 15.1% | ||
| Q2 25 | 22.2% | -11.1% | ||
| Q1 25 | 21.8% | -52.2% | ||
| Q4 24 | 22.2% | -81.2% | ||
| Q3 24 | 26.9% | -89.3% | ||
| Q2 24 | 23.4% | -125.1% | ||
| Q1 24 | 18.6% | -336.5% |
| Q4 25 | 8.1% | — | ||
| Q3 25 | 18.5% | 15.6% | ||
| Q2 25 | 12.5% | -11.1% | ||
| Q1 25 | 10.0% | -50.4% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 17.8% | -87.1% | ||
| Q2 24 | 12.0% | -130.1% | ||
| Q1 24 | 7.8% | -328.9% |
| Q4 25 | $0.45 | $0.04 | ||
| Q3 25 | $1.27 | $0.28 | ||
| Q2 25 | $0.71 | $-0.14 | ||
| Q1 25 | $0.49 | $-0.47 | ||
| Q4 24 | $0.70 | $-0.71 | ||
| Q3 24 | $1.17 | $-0.70 | ||
| Q2 24 | $0.64 | $-0.91 | ||
| Q1 24 | $0.36 | $-1.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.7M | $93.0M |
| Total DebtLower is stronger | $1.9B | — |
| Stockholders' EquityBook value | $1.5B | $114.8M |
| Total Assets | $5.1B | $605.2M |
| Debt / EquityLower = less leverage | 1.23× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.7M | $93.0M | ||
| Q3 25 | $11.3M | $110.9M | ||
| Q2 25 | $19.8M | $75.2M | ||
| Q1 25 | $23.7M | $61.9M | ||
| Q4 24 | $11.1M | $58.5M | ||
| Q3 24 | $4.0M | $36.4M | ||
| Q2 24 | $22.8M | $32.3M | ||
| Q1 24 | $4.5M | $43.3M |
| Q4 25 | $1.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | $114.8M | ||
| Q3 25 | $1.5B | $73.6M | ||
| Q2 25 | $1.5B | $32.7M | ||
| Q1 25 | $1.4B | $32.8M | ||
| Q4 24 | $1.4B | $59.1M | ||
| Q3 24 | $1.3B | $-30.5M | ||
| Q2 24 | $1.3B | $15.1M | ||
| Q1 24 | $1.2B | $74.1M |
| Q4 25 | $5.1B | $605.2M | ||
| Q3 25 | $5.0B | $538.6M | ||
| Q2 25 | $4.8B | $555.3M | ||
| Q1 25 | $4.7B | $548.8M | ||
| Q4 24 | $4.7B | $594.1M | ||
| Q3 24 | $4.6B | $504.4M | ||
| Q2 24 | $4.4B | $551.1M | ||
| Q1 24 | $4.4B | $663.5M |
| Q4 25 | 1.23× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.5M | $60.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.5M | $60.7M | ||
| Q3 25 | $77.3M | $14.3M | ||
| Q2 25 | $60.8M | $5.0M | ||
| Q1 25 | $43.2M | $-42.2M | ||
| Q4 24 | $41.5M | $-35.7M | ||
| Q3 24 | $53.5M | $-42.5M | ||
| Q2 24 | $49.3M | $-40.2M | ||
| Q1 24 | $51.2M | $-119.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $14.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-40.3M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 8.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -74.5% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 3.92× | — | ||
| Q3 25 | 1.71× | 0.56× | ||
| Q2 25 | 2.47× | — | ||
| Q1 25 | 2.61× | — | ||
| Q4 24 | 1.81× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 2.38× | — | ||
| Q1 24 | 4.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTO
| Water Utility Services | $191.0M | 96% |
| Other | $8.4M | 4% |
TVTX
| FILSPARI | $103.3M | 80% |
| Tiopronin Products | $23.3M | 18% |
| License | $3.1M | 2% |
